What if a vaccine, given to patients just before or after arriving at the hospital, could protect them against lethal superbugs that lurk in healthcare settings?
Tenpoint Therapeutics launches with $70M to restore vision with stem cell therapies and ‘reprogramming’ medicines
Although numerous biotech companies are developing gene therapies to correct eyesight, these approaches largely require the affected cells to remain intact — while many forms